← Back to Search

Physical Activity Monitoring for Brain Cancer

N/A
Recruiting
Led By Shiao-Pei S Weathers
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosed with a glioma and going to receive at least 4 weeks of RT at MDACC at the Texas Medical Center campus with at least 20 fractions
Karnofsky performance status (KPS) of 70 or above
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 months
Awards & highlights

Study Summary

This trial is testing whether monitoring step count could be a helpful measure of physical activity for newly diagnosed glioma patients undergoing radiation therapy.

Who is the study for?
This trial is for English-speaking patients with a new glioma diagnosis who are starting at least 4 weeks of radiation therapy. Participants must have a good performance status, meaning they can carry out daily activities without significant help, be able to consent, own a smartphone, have Wi-Fi access, and not already use wearable activity trackers.Check my eligibility
What is being tested?
The study is testing if using devices like FitBits or pedometers to monitor steps can help understand physical activity levels in patients undergoing radiation therapy for brain tumors. It aims to see if tracking steps could improve life quality and manage symptoms during treatment.See study design
What are the potential side effects?
Since this trial involves non-invasive monitoring tools such as FitBit and questionnaires rather than medications or invasive procedures, there are no direct medical side effects expected from the interventions being tested.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have a glioma and will undergo radiation therapy for at least 4 weeks.
Select...
I am able to care for myself but may not be able to do active work.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Consent rate
Fitbit adherence rate
Retention rate
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group II (FitBit)Experimental Treatment3 Interventions
Patients wear a FitBit for step count monitoring over 6 weeks.
Group II: Group I (pedometer)Active Control3 Interventions
Patients wear a pedometer for step count monitoring over 6 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
FitBit
2017
N/A
~480

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,627 Previous Clinical Trials
40,927,297 Total Patients Enrolled
M.D. Anderson Cancer CenterLead Sponsor
2,962 Previous Clinical Trials
1,803,315 Total Patients Enrolled
Shiao-Pei S WeathersPrincipal InvestigatorM.D. Anderson Cancer Center
4 Previous Clinical Trials
203 Total Patients Enrolled

Media Library

FitBit Clinical Trial Eligibility Overview. Trial Name: NCT04186832 — N/A
Brain Tumor Research Study Groups: Group II (FitBit), Group I (pedometer)
Brain Tumor Clinical Trial 2023: FitBit Highlights & Side Effects. Trial Name: NCT04186832 — N/A
FitBit 2023 Treatment Timeline for Medical Study. Trial Name: NCT04186832 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment of participants currently underway for this experiment?

"Currently, the research team is seeking volunteers for this medical trial. It was originally posted on September 28th 2020 and recently updated November 28th 2022 as indicated by clinicaltrials.gov."

Answered by AI

How many volunteers are enrolled in this experiment?

"Affirmative. Clinicaltrials.gov reveals that this medical experiment is actively enrolling participants, after being first posted on 28th September 2020 and recently amended on the 28th November 2022. 50 individuals need to be sourced from one site for inclusion in this trial."

Answered by AI
~9 spots leftby Dec 2024